Skip to main content

and
  1. Article

    Open Access

    Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma

    Lysosomal sequestration of anti-cancer compounds reduces drug availability at intracellular target sites, thereby limiting drug-sensitivity and inducing chemoresistance. For hepatocellular carcinoma (HCC), sor...

    Jacopo Gavini, Noëlle Dommann, Manuel O. Jakob, Adrian Keogh in Cell Death & Disease (2019)